Evidence map›Paper›PMID 33826758›Full record

ReviewCancer2021

Characterizing participants in the North Carolina Breast and Cervical Cancer Control Program: A retrospective review of 90,000 women.

Sarah D Tait, Yi Ren, Cushanta C Horton, Sachiko M Oshima, Samantha M Thomas, Sherry Wright, Awanya Caesar, Jennifer K Plichta, E Shelley Hwang, Rachel A Greenup and 7 more

Open access · greenAbstract readReview
In one paragraph

Review in Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Sarah D TaitDuke University School of Medicine, Durham, North Carolina.
Yi RenDuke University School of Medicine, Durham, North Carolina.
Cushanta C HortonNorth Carolina Department of Health and Human Services, Raleigh, North Carolina.
Sachiko M OshimaDuke University School of Medicine, Durham, North Carolina.ORCID 0000-0001-8015-4058
Samantha M ThomasDuke University School of Medicine, Durham, North Carolina.
Sherry WrightNorth Carolina Department of Health and Human Services, Raleigh, North Carolina.
Awanya CaesarLincoln Community Health Center, Durham, North Carolina.
Jennifer K PlichtaDuke University School of Medicine, Durham, North Carolina.
E Shelley HwangDuke University School of Medicine, Durham, North Carolina.
Rachel A GreenupDuke University School of Medicine, Durham, North Carolina.
Laura H RosenbergerDuke University School of Medicine, Durham, North Carolina.
Gayle D DiLallaDuke University School of Medicine, Durham, North Carolina.
Carolyn S MenendezDuke University School of Medicine, Durham, North Carolina.
Lisa TolnitchDuke University School of Medicine, Durham, North Carolina.
Terry HyslopDuke University School of Medicine, Durham, North Carolina.
Debi NelsonNorth Carolina Department of Health and Human Services, Raleigh, North Carolina.
Oluwadamilola M FayanjuDuke University School of Medicine, Durham, North Carolina.ORCID 0000-0002-0876-975X
Duke University · USNC Department of Health and Human Services · USCommunity Health Center · US

Funding

Women's Cancer Research ProgramP30CA014236 · NCI · DUKE UNIVERSITY · PI JOHN N. NORTON · 1985 to 2026
$174.8M
Using Modifiable Risk Factors to Predict Inferior Care and Survival after Breast Cancer Diagnosis: A Novel Approach to Addressing Health DisparitiesK08CA241390 · NCI · UNIVERSITY OF PENNSYLVANIA · PI FAYANJU, OLUWADAMILOLA M. · 2019 to 2023
$1.1M
NCI NIH HHS K08 CA241390NCI NIH HHS P30 CA014236NIH HHS 1K08CA241390
6 · The paper itself

Abstract

backgroundThe North Carolina Breast and Cervical Cancer Control Program (NC BCCCP) provides breast cancer screening services to underserved women to mitigate disparities in access to care. The authors sought to characterize this understudied population.

methodsWomen 21 years old or older who underwent their first breast cancer screen through NC BCCCP from 2008 to 2018 were included. Demographic factors associated with the timeline of care and odds of a breast cancer diagnosis were identified with negative binomial and logistic regression, respectively.

resultsOf the 88,893 women identified, 45.5% were non-Hispanic (NH) White, 30.9% were NH Black, 19.6% were Hispanic, 1.7% were American Indian, and 1.1% were Asian. Breast cancer was diagnosed in 2.5% of the women (n = 2255). Hispanic women were the least likely to be diagnosed with breast cancer (odds ratio vs NH White women, 0.40; 95% confidence interval [CI], 0.34-0.47). Among patients with breast pathology, the median time to diagnosis was 19 days (interquartile range [IQR], 10-33 days), and the time to treatment was 33 days (IQR, 19-54 days). After adjustments, a longer time to diagnosis was significantly associated with age (incidence rate ratio [IRR], 1.01; 95% CI, 1.01-1.02) and being NH Black (vs NH White; IRR, 1.17; 95% CI, 1.06-1.29). A longer time to treatment was significantly associated with age (IRR, 1.01; 95% CI, 1.01-1.01), being NH Black (vs NH White; IRR, 1.20; 95% CI, 1.10-1.31), and being Hispanic (vs NH White; IRR, 1.22; 95% CI, 1.05-1.41).

conclusionsNC BCCCP participants with breast cancer received treatment within approximately 1 month of presentation, and this finding aligns with quality care benchmarks. Nevertheless, racial/ethnic disparities in timeliness of care persist, and this suggests opportunities for improvement. LAY SUMMARY: This review of approximately 90,000 participants in a breast cancer screening program for uninsured and underinsured women highlights the importance of safety net programs in providing timely care to underserved patients. The authors found that the North Carolina Breast and Cervical Cancer Control Program met timeliness benchmarks from the Centers for Disease Control and Prevention across all racial/ethnic groups. However, non-Hispanic Black women experienced relative delays in the time to diagnosis, and both non-Hispanic Black women and Hispanic women experienced relative delays in the time to treatment. These findings demonstrate how racial/ethnic disparities in the timeliness of care can persist even within a program intended to reduce barriers to access.

Indexed as

Breast NeoplasmsRacial GroupsAdultEarly Detection of CancerEthnicityFemaleHealthcare DisparitiesHumansNorth CarolinaRetrospective StudiesUnited StatesYoung Adultbreast neoplasmscancer screeninghealth care disparitiesinsurance

Identifiers

PMID33826758
PMCPMC8320193
OpenAlexW3141752980

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.